|
Dr. Langer has served as a Managing Partner of Phoenix IP Ventures, a venture capital firm, since August 2005. Prior to joining Phoenix IP Ventures, he was President, North America, of Dr. Reddy’s Laboratories Limited, an emerging global pharmaceutical company. Previously, Dr. Langer was with GlaxoSmithKline for nine years. His last position at GSK was Senior Vice President, Project and Portfolio Management. In addition, Dr. Langer was responsible for Alliance Management and was a member of the R&D Executive Team. Prior to the merger of Glaxo Wellcome and SmithKline Beecham, he was Senior Vice President, Product Development Strategy and Senior Vice President, Research and Development, Healthcare Services for SmithKline Beecham. He also held management positions with Searle, Abbott, and Eli Lilly. Dr. Langer served as the first President and Chief Executive Officer of Neose Technologies, Inc. Dr. Langer earned an M.D. from Georgetown University School of Medicine, a J.D. (cum laude) from Harvard Law School, and a B.A. in Biology from Columbia University. Dr. Langer also serves on the Boards of Myriad Genetics, Inc. and Cytogen Corporation, and is a Clinical Professor, Department of Psychiatry, Georgetown University School of Medicine. | 